{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:23:15Z","timestamp":1792664595284,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China under Grant","award":["No. Q24H100011"],"award-info":[{"award-number":["No. Q24H100011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04009-0","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:13:07Z","timestamp":1761315187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Single-cell stemness analysis highlights Midkine-LRP1 pathway and identifies new bladder cancer subtypes"],"prefix":"10.1186","volume":"25","author":[{"given":"Cheng","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenggan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengda","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"1","key":"4009_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.eururo.2024.11.026","volume":"88","author":"MP St-Laurent","year":"2024","unstructured":"St-Laurent MP, et al. Increasing life expectancy in patients with genitourinary malignancies: impact of treatment burden on disease management and quality of life. Eur Urol. 2024;88(1):11\u201320.","journal-title":"Eur Urol"},{"issue":"5","key":"4009_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.eururo.2024.12.002","volume":"87","author":"P Scilipoti","year":"2024","unstructured":"Scilipoti P, et al. The financial burden of localized and metastatic bladder cancer. Eur Urol. 2024;87(5):536\u201350.","journal-title":"Eur Urol"},{"issue":"3","key":"4009_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"4009_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.21.02928","volume":"40","author":"GP Sonpavde","year":"2022","unstructured":"Sonpavde GP, Mouw KW, Mossanen M. Therapy for muscle-invasive urothelial carcinoma: controversies and dilemmas. J Clin Oncol. 2022;40(12):1275\u201380.","journal-title":"J Clin Oncol"},{"issue":"19","key":"4009_CR5","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, et al. Bladder cancer: a review. JAMA. 2020;324(19):1980\u201391.","journal-title":"JAMA"},{"key":"4009_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4009_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13073-022-01056-4","volume":"14","author":"A Goel","year":"2022","unstructured":"Goel A, et al. Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes. Genome Med. 2022;14(1):59.","journal-title":"Genome Med"},{"key":"4009_CR8","doi-asserted-by":"crossref","unstructured":"Alfred Witjes, J., et al., European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol, 2023.","DOI":"10.1016\/j.eururo.2023.08.016"},{"issue":"2","key":"4009_CR9","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4009_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","volume":"73","author":"GP Paner","year":"2018","unstructured":"Paner GP, et al. Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol. 2018;73(4):560\u20139.","journal-title":"Eur Urol"},{"key":"4009_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semcancer.2023.03.002","volume":"91","author":"G Papavasileiou","year":"2023","unstructured":"Papavasileiou G, et al. Obesity and main urologic cancers: current systematic evidence, novel biological mechanisms, perspectives and challenges. Semin Cancer Biol. 2023;91:70\u201398.","journal-title":"Semin Cancer Biol"},{"key":"4009_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.950241","volume":"10","author":"J Tan","year":"2022","unstructured":"Tan J, et al. The origin and evolution of bladder cancer stem cells. Front Cell Dev Biol. 2022;10:950241.","journal-title":"Front Cell Dev Biol"},{"key":"4009_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054760","author":"L Ma","year":"2023","unstructured":"Ma L, et al. Crosstalk between mesenchymal stem cells and cancer stem cells reveals a novel stemness-related signature to predict prognosis and immunotherapy responses for bladder cancer patients. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24054760.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4009_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","volume":"14","author":"Y Lei","year":"2021","unstructured":"Lei Y, et al. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol. 2021;14(1):91.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"4009_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","volume":"174","author":"A Zeisel","year":"2018","unstructured":"Zeisel A, et al. Molecular architecture of the mouse nervous system. Cell. 2018;174(4):999-1014.e22.","journal-title":"Cell"},{"issue":"2","key":"4009_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.12.010","volume":"29","author":"J Jansen","year":"2022","unstructured":"Jansen J, et al. SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Cell Stem Cell. 2022;29(2):217-231.e8.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"4009_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis R, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50(5):1317-1334.e10.","journal-title":"Immunity"},{"issue":"1","key":"4009_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-021-01392-w","volume":"20","author":"J Xu","year":"2021","unstructured":"Xu J, et al. Using single-cell sequencing technology to detect circulating tumor cells in solid tumors. Mol Cancer. 2021;20(1):104.","journal-title":"Mol Cancer"},{"issue":"6","key":"4009_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205395","volume":"10","author":"YM Liu","year":"2023","unstructured":"Liu YM, et al. Combined single-cell and spatial transcriptomics reveal the metabolic evolvement of breast cancer during early dissemination. Adv Sci (Weinh). 2023;10(6):e2205395.","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"4009_CR20","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.ccell.2022.08.005","volume":"40","author":"B Salom\u00e9","year":"2022","unstructured":"Salom\u00e9 B, et al. NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer. Cancer Cell. 2022;40(9):1027-1043.e9.","journal-title":"Cancer Cell"},{"issue":"12","key":"4009_CR21","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. Consensusclusterplus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"1","key":"4009_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13046-019-1254-4","volume":"38","author":"HG Xiong","year":"2019","unstructured":"Xiong HG, et al. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2019;38(1):278.","journal-title":"J Exp Clin Cancer Res"},{"key":"4009_CR23","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.2147\/OTT.S147717","volume":"10","author":"R Huang","year":"2017","unstructured":"Huang R, Liao X, Li Q. Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia. Onco Targets Ther. 2017;10:5243\u201354.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"4009_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216834","volume":"14","author":"Z Li","year":"2019","unstructured":"Li Z, Jiang C, Yuan Y. TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma. PLoS ONE. 2019;14(5):e0216834.","journal-title":"PLoS ONE"},{"issue":"3","key":"4009_CR25","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"4009_CR26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41568-019-0213-x","volume":"19","author":"ED Williams","year":"2019","unstructured":"Williams ED, et al. Controversies around epithelial-mesenchymal plasticity in cancer metastasis. Nat Rev Cancer. 2019;19(12):716\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"4009_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrurol.2012.142","volume":"9","author":"PL Ho","year":"2012","unstructured":"Ho PL, Kurtova A, Chan KS. Normal and neoplastic urothelial stem cells: getting to the root of the problem. Nat Rev Urol. 2012;9(10):583\u201394.","journal-title":"Nat Rev Urol"},{"key":"4009_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.addr.2014.11.013","volume":"82","author":"O Lam Van Ba","year":"2015","unstructured":"Lam Van Ba O, et al. Bladder tissue engineering: a literature review. Adv Drug Deliv Rev. 2015;82:31.","journal-title":"Adv Drug Deliv Rev"},{"key":"4009_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.semcancer.2018.09.010","volume":"57","author":"L Dong","year":"2019","unstructured":"Dong L, et al. The special stemness functions of Tbx3 in stem cells and cancer development. Semin Cancer Biol. 2019;57:105\u201310.","journal-title":"Semin Cancer Biol"},{"key":"4009_CR30","doi-asserted-by":"publisher","first-page":"1166189","DOI":"10.3389\/fimmu.2023.1166189","volume":"14","author":"O Sizova","year":"2023","unstructured":"Sizova O, et al. Multi-faceted role of LRP1 in the immune system. Front Immunol. 2023;14:1166189.","journal-title":"Front Immunol"},{"key":"4009_CR31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202207","author":"AM Nikolakopoulou","year":"2021","unstructured":"Nikolakopoulou AM, et al. Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20202207.","journal-title":"J Exp Med"},{"key":"4009_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jconrel.2018.04.035","volume":"279","author":"H Ruan","year":"2018","unstructured":"Ruan H, et al. A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery. J Control Release. 2018;279:306\u201315.","journal-title":"J Control Release"},{"key":"4009_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2019.04.031","volume":"303","author":"Q Guo","year":"2019","unstructured":"Guo Q, et al. LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases. J Control Release. 2019;303:117\u201329.","journal-title":"J Control Release"},{"issue":"1","key":"4009_CR34","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1038\/s41467-021-25673-6","volume":"12","author":"H Mao","year":"2021","unstructured":"Mao H, et al. Endothelium-specific depletion of LRP1 improves glucose homeostasis through inducing osteocalcin. Nat Commun. 2021;12(1):5296.","journal-title":"Nat Commun"},{"key":"4009_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.matbio.2019.12.001","volume":"88","author":"J Schnieder","year":"2020","unstructured":"Schnieder J, et al. Loss of LRP1 promotes acquisition of contractile-myofibroblast phenotype and release of active TGF-\u03b21 from ECM stores. Matrix Biol. 2020;88:69\u201388.","journal-title":"Matrix Biol"},{"issue":"20","key":"4009_CR36","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1016\/j.devcel.2021.09.015","volume":"56","author":"W Bian","year":"2021","unstructured":"Bian W, et al. Low-density-lipoprotein-receptor-related protein 1 mediates Notch pathway activation. Dev Cell. 2021;56(20):2902-2919.e8.","journal-title":"Dev Cell"},{"issue":"1","key":"4009_CR37","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.1038\/s41467-022-35649-9","volume":"13","author":"L Sui","year":"2022","unstructured":"Sui L, et al. PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression. Nat Commun. 2022;13(1):7959.","journal-title":"Nat Commun"},{"issue":"10","key":"4009_CR38","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1038\/s41388-019-1124-8","volume":"39","author":"PS Filippou","year":"2020","unstructured":"Filippou PS, Karagiannis GS, Constantinidou A. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene. 2020;39(10):2040\u201354.","journal-title":"Oncogene"},{"issue":"12","key":"4009_CR39","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1111\/bph.12601","volume":"171","author":"DR Jones","year":"2014","unstructured":"Jones DR. Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases. Br J Pharmacol. 2014;171(12):2925\u201339.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4009_CR40","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/cancers2020624","volume":"2","author":"H Jono","year":"2010","unstructured":"Jono H, Ando Y. Midkine: a novel prognostic biomarker for cancer. Cancers (Basel). 2010;2(2):624\u201341.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4009_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7150\/ijbs.74227","volume":"19","author":"X Han","year":"2023","unstructured":"Han X, et al. Mir-1275 targets MDK\/AKT signaling to inhibit breast cancer chemoresistance by lessening the properties of cancer stem cells. Int J Biol Sci. 2023;19(1):89\u2013103.","journal-title":"Int J Biol Sci"},{"key":"4009_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ebiom.2019.01.067","volume":"41","author":"X Meng","year":"2019","unstructured":"Meng X, et al. DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma. EBioMedicine. 2019;41:185\u201399.","journal-title":"EBioMedicine"},{"issue":"17","key":"4009_CR43","doi-asserted-by":"publisher","first-page":"7532","DOI":"10.7150\/thno.77528","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, et al. Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution. Theranostics. 2022;12(17):7532\u201349.","journal-title":"Theranostics"},{"issue":"1","key":"4009_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13046-018-0814-3","volume":"37","author":"J Lu","year":"2018","unstructured":"Lu J, et al. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK\/AKT pathway in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2018;37(1):147.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4009_CR45","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1038\/s41467-022-32673-7","volume":"13","author":"Y Tang","year":"2022","unstructured":"Tang Y, Kwiatkowski DJ, Henske EP. Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment. Nat Commun. 2022;13(1):5018.","journal-title":"Nat Commun"},{"issue":"11","key":"4009_CR46","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.7150\/thno.41450","volume":"10","author":"I L\u00f3pez-Valero","year":"2020","unstructured":"L\u00f3pez-Valero I, et al. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells. Theranostics. 2020;10(11):5120\u201336.","journal-title":"Theranostics"},{"issue":"4","key":"4009_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s44321-024-00050-0","volume":"16","author":"M Inayatullah","year":"2024","unstructured":"Inayatullah M, et al. Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer. EMBO Mol Med. 2024;16(4):823\u201353.","journal-title":"EMBO Mol Med"},{"key":"4009_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104981","volume":"159","author":"Y Cao","year":"2020","unstructured":"Cao Y, et al. Oroxylin a suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis. Pharmacol Res. 2020;159:104981.","journal-title":"Pharmacol Res"},{"issue":"1","key":"4009_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-020-01821-6","volume":"40","author":"Q Chen","year":"2021","unstructured":"Chen Q, et al. ACTN1 supports tumor growth by inhibiting hippo signaling in hepatocellular carcinoma. J Exp Clin Cancer Res. 2021;40(1):23.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4009_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","volume":"79","author":"A Lapitz","year":"2023","unstructured":"Lapitz A, et al. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma. J Hepatol. 2023;79(1):93\u2013108.","journal-title":"J Hepatol"},{"issue":"7","key":"4009_CR51","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ejcb.2017.07.005","volume":"96","author":"H Yamaguchi","year":"2017","unstructured":"Yamaguchi H et al. Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells. Euro J Cell Bio. 2017;96(7):685-94.","journal-title":"European Journal of Cell Biology"},{"issue":"7","key":"4009_CR52","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1074\/mcp.M700590-MCP200","volume":"7","author":"K Thorsen","year":"2008","unstructured":"Thorsen K, et al. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol Cell Proteomics. 2008;7(7):1214\u201324.","journal-title":"Mol Cell Proteomics"},{"key":"4009_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.gene.2017.05.054","volume":"626","author":"Z Wu","year":"2017","unstructured":"Wu Z, et al. Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer. Gene. 2017;626:407\u201313.","journal-title":"Gene"},{"key":"4009_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10255842.2025.2532034","volume":"9","author":"L Guan","year":"2025","unstructured":"Guan L, et al. Myeloid cell differentiation-related gene signature predicts the prognosis and immunotherapy response in bladder cancer. Comput Methods Biomech Biomed Engin. 2025;9:1\u20134.","journal-title":"Comput Methods Biomech Biomed Engin"},{"issue":"2","key":"4009_CR55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ceb.2009.02.005","volume":"21","author":"T Pawson","year":"2009","unstructured":"Pawson T, Kofler M. Kinome signaling through regulated protein-protein interactions in normal and cancer cells. Curr Opin Cell Biol. 2009;21(2):147\u201353.","journal-title":"Curr Opin Cell Biol"},{"issue":"11","key":"4009_CR56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2214324120","volume":"120","author":"J Wang","year":"2023","unstructured":"Wang J, et al. Cryo-EM structure of the human chemerin receptor 1-Gi protein complex bound to the C-terminal nonapeptide of chemerin. Proc Natl Acad Sci U S A. 2023;120(11):e2214324120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4009_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.watres.2022.118793","volume":"221","author":"B Wu","year":"2022","unstructured":"Wu B, et al. Mechanism insights into liquid polarity regulation for enhanced dewatering of waste-activated sludge: specifically focusing on the solid-liquid affinity reduction depending on phase-transfer and conformational features of amphiphilic protein. Water Res. 2022;221:118793.","journal-title":"Water Res"},{"issue":"4","key":"4009_CR58","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1021\/acs.nanolett.0c04587","volume":"21","author":"M Du","year":"2021","unstructured":"Du M, et al. Noncovalent self-assembly of protein crystals with tunable structures. Nano Lett. 2021;21(4):1749\u201357.","journal-title":"Nano Lett"},{"issue":"13","key":"4009_CR59","volume":"48","author":"XJ Lu","year":"2020","unstructured":"Lu XJ. DSSR-enabled innovative schematics of 3D nucleic acid structures with PyMOL. Nucleic Acids Res. 2020;48(13):e74.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"4009_CR60","doi-asserted-by":"publisher","first-page":"W345","DOI":"10.1093\/nar\/gkz424","volume":"47","author":"L Jendele","year":"2019","unstructured":"Jendele L, et al. Prankweb: a web server for ligand binding site prediction and visualization. Nucleic Acids Res. 2019;47(W1):W345-w349.","journal-title":"Nucleic Acids Res"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04009-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04009-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04009-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T15:03:29Z","timestamp":1761318209000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-04009-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4009"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04009-0","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"376"}}